Updated Visitor Restriction Policy

Effective Monday, April 5, 2021, Rutland Regional has updated the visitation policy to allow for limited visitation. Please read the full policy before coming to the hospital or one of the clinics:

Visitor Restriction Policy

Skip to Content

Breast-Adjuvant Therapy Comparing Chemotherapy Alone to Chemotherapy Plus Trastuzumab

Objective

NSABP B-47 A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer

To determine whether the addition of the drug trastuzumab (Herceptin) to chemotherapy improves invasive disease-free survival in women with resected node-positive or high-risk node negative breast cancer with reported HER-2 low by all HER 2 testing performed

Sponsor(s)
National Surgical Adjuvant Breast and Bowel Project, an NCI Cooperative Group
Contact
Rebecca Denofer, RN, OCN at 802-747-1692
or rdenofer@rrmc.org

RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111

© 2021 Rutland Medical Center